Treatment of Pregnant Women with Ivermectin during Mass Drug Distribution: Time to Investigate Its Safety and Potential Benefits

To date, pregnant women are excluded from programmes delivering community-directed treatment of ivermectin (CDTI) for onchocerciasis and preventive chemotherapy of other helminthiases because of concerns over ivermectin safety during pregnancy. This systematic exclusion sustains an infection reservo...

Descripción completa

Detalles Bibliográficos
Autores principales: Erber, Astrid Christine, Ariyo, Esther, Olliaro, Piero, Nicolas, Patricia, Chaccour, Carlos, Colebunders, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703637/
https://www.ncbi.nlm.nih.gov/pubmed/34959543
http://dx.doi.org/10.3390/pathogens10121588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703637/
https://www.ncbi.nlm.nih.gov/pubmed/34959543
http://dx.doi.org/10.3390/pathogens10121588

Ejemplares similares